1999
DOI: 10.1097/00006250-199912000-00014
|View full text |Cite
|
Sign up to set email alerts
|

Maternal Central Hemodynamics in Hypertensive Disorders of Pregnancy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

23
187
3
2

Year Published

2004
2004
2018
2018

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 239 publications
(215 citation statements)
references
References 23 publications
23
187
3
2
Order By: Relevance
“…21,22 Although some echocardiographic studies showed that women developing hypertensive complications during pregnancy may have different LA dimensions than controls, [23][24][25][26] the potential link between LA abnormality detected early in pregnancy by echocardiography or ECG and development of hypertensive disorders remains elusive. However, some possible mechanisms are supported by epidemiological data and experimental models.…”
Section: Discussionmentioning
confidence: 99%
“…21,22 Although some echocardiographic studies showed that women developing hypertensive complications during pregnancy may have different LA dimensions than controls, [23][24][25][26] the potential link between LA abnormality detected early in pregnancy by echocardiography or ECG and development of hypertensive disorders remains elusive. However, some possible mechanisms are supported by epidemiological data and experimental models.…”
Section: Discussionmentioning
confidence: 99%
“…10 In contrast late-PE, which is usually associated with normal placentation and fetal growth, 11,12 is thought to be a manifestation of an underlying metabolic disorder with increased insulin resistance. [13][14][15] Insulin-like growth factor-binding protein 3 (IGFBP-3) belongs to the family of IGFBPs, which determine the bioavailability and activity of the IGFs. 16,17 In the circulation, IGFBP-3 binds to approximately 95% of IGF-I and IGF-II and this complex prolongs the half-life of IGFs and protects them from degradation.…”
Section: Introductionmentioning
confidence: 99%
“…They concluded that measurement of CO in the second trimester identified women at risk for PE and treatment with atenolol decreased the incidence of PE. Bosio 13 conducted a longitudinal study of 400 primigravidae who were monitored throughout pregnancy using doppler echocardiography to document maternal central hemodynamics during preclinical and clinical phases of nonprotienuric gestational hypertension and PE. Multinomial logistic regression was used to identify variables associated with risk of hypertension.…”
Section: Discussionmentioning
confidence: 99%